Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis (DES)
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Response to disease modifying therapies in African Americans with multiple sclerosis.
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
Age-Dependent Seroprevalence of JCV Antibody in Children.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Pathology and disease mechanisms in different stages of multiple sclerosis.
[Neuromyelitis optica spectrum disorder: a case report].
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Acid-sensing ion channels: trafficking and synaptic function.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
France Banned AB Science Drug Studies Because of Side Effects
Extreme Stability of Chitotriosidase in Cerebrospinal Flulid makes it a Suitable Marker for Microglial Activation in Clinical Trials.
Imaging of the spine at 3 tesla.
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.

Pages